Anilkumar Surendrakumar Gandhi

This inventor holds 16 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Rubicon Research Private Limited, Ezra Pharma LLC, Breckenridge Pharmaceutical, Inc.. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anilkumar Surendrakumar Gandhi. Retrieved from https://idiyas.com/inventor/anilkumar-surendrakumar-gandhi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 18)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 56(Granted Patents)

Location History:

Maharashtra, IN (2019)
Mumbai, IN (2013 - 2023)

Company Filing History:

11 out of 12

Rubicon Research Private Limited

Breckenridge Pharmaceutical, Inc.

Psm Healthcare Limited

patents

6. 1 out of 1

Towa Pharmaceutical Europe, S.l. Unipersonal

patent

7. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11752142 - Oral pharmaceutical compositions of dabigatran etexilate (2023-09-12),

2. 11013729 - Oral pharmaceutical compositions of dabigatran etexilate (2021-05-25),

3. 10806685 - Oral care compositions (2020-10-20),

4. 10463623 - Compositions exhibiting delayed transit through the gastrointestinal tract (2019-11-05),

5. 10391060 - Particulate delivery systems (2019-08-27),

6. 10286024 - [object Object] (2019-05-14),

7. 10010529 - Extended release pharmaceutical formulations with controlled impurity levels (2018-07-03),

8. 9801821 - Stabilized vitamin D formulations (2017-10-31),

9. 9687475 - Extended release pharmaceutical formulations with controlled impurity levels (2017-06-27),

10. 9675585 - Extended release pharmaceutical formulations (2017-06-13),

11. 9629915 - Sustained release dosage form (2017-04-25),

12. 9492451 - Stable compositions of tetrahydrobiopterin (2016-11-15),

13. 9295643 - [object Object] (2016-03-29),

14. 9198862 - Dispersible tablet composition (2015-12-01),

15. 8920837 - Sustained release dosage form (2014-12-30),

Title: Anilkumar Surendrakumar Gandhi - Pioneering Inventor from Mumbai

Introduction: Anilkumar Surendrakumar Gandhi is a distinguished inventor hailing from the vibrant city of Mumbai, India. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology through his groundbreaking inventions.

Latest Patents: Anilkumar Surendrakumar Gandhi holds several patents in various technological domains, showcasing his versatility and creativity as an inventor. His recent patents focus on sustainable energy solutions and cutting-edge advancements in the healthcare industry.

Career Highlights: Throughout his illustrious career, Anilkumar Surendrakumar Gandhi has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His work has not only garnered critical acclaim but has also positively impacted numerous industries.

Collaborations: Anilkumar Surendrakumar Gandhi has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work in multidisciplinary teams has led to the development of revolutionary products that have changed the way we perceive technology.

Conclusion: Anilkumar Surendrakumar Gandhi's relentless pursuit of innovation and his commitment to excellence make him a true trailblazer in the world of inventions. His contributions have left an indelible mark on the technological landscape, inspiring future generations of inventors to dream big and think outside the box.

Profile summary based on public USPTO records.